Scarica l'app Stockscreener
1.73
0.00%
0.00
Dopo l'orario di chiusura:
1.77
0.04
+2.31%
Precedente Chiudi:
$1.73
Aprire:
$1.75
Volume 24 ore:
5.54M
Relative Volume:
0.76
Capitalizzazione di mercato:
$15.78M
Reddito:
-
Utile/perdita netta:
$-14.07M
Rapporto P/E:
-0.1237
EPS:
-13.99
Flusso di cassa netto:
$-12.56M
1 W Prestazione:
-17.62%
1M Prestazione:
+187.18%
6M Prestazione:
+147.04%
1 anno Prestazione:
-53.12%
Intervallo 1D:
$1.67
$1.90
Intervallo di 1 settimana:
$1.6582
$2.1396
Portata 52W:
$0.53
$4.318
Palisade Bio Inc Stock (PALI) Company Profile
Nome
Palisade Bio Inc
Settore
Industria
Telefono
(858) 704-4900
Indirizzo
7750 EL CAMINO REAL, SUITE 5200, CARLSBAD
Confronta PALI con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PALI
Palisade Bio Inc
|
1.73 | 226.74M | 0 | -14.07M | -12.56M | -13.99 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.61 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.07 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.17 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
837.28 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
318.02 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Palisade Bio Inc Borsa (PALI) Ultime notizie
RA CAPITAL MANAGEMENT, L.P. Acquires Significant Stake in Palisa - GuruFocus
Palisade Bio Regains Nasdaq Compliance on Stock Price - TipRanks
Palisade Bio regains Nasdaq compliance and reports cash position update - Investing.com
What technical patterns form on Palisade Bio Inc. (7NS0) stock chartsWeekly Market Report & Daily Chart Pattern Signals - newser.com
Palisade Bio Provides Corporate and Compliance Update - TradingView
Is Palisade Bio Inc. showing signs of accumulationEarnings Risk Summary & Reliable Price Breakout Signals - newser.com
What MACD and RSI say about Palisade Bio Inc.2025 Buyback Activity & Free Long-Term Investment Growth Plans - newser.com
Can Palisade Bio Inc. (7NS0) stock sustain breakout momentumJuly 2025 Pullbacks & Pattern Based Trade Signal System - newser.com
Can volume confirm reversal in Palisade Bio Inc.2025 Breakouts & Breakdowns & Fast Entry and Exit Trade Plans - newser.com
What’s next for Palisade Bio Inc. stock pricePortfolio Value Report & Risk Managed Trade Strategies - newser.com
Price action breakdown for Palisade Bio Inc.Market Movement Recap & AI Powered Market Entry Strategies - newser.com
Using data filters to optimize entry into Palisade Bio Inc.July 2025 Catalysts & Community Trade Idea Sharing Platform - newser.com
Is Palisade Bio Inc. stock dividend yield sustainable2025 Volume Leaders & Technical Confirmation Trade Alerts - newser.com
How moving averages guide Palisade Bio Inc. tradingTrade Ideas & Fast Moving Market Watchlists - newser.com
Sector ETF performance correlation with Palisade Bio Inc.Portfolio Value Summary & Weekly Watchlist of Top Performers - newser.com
Palisade Bio Granted Canadian Patent Covering Composition of Lead Product Candidate PALI-2108 - GlobeNewswire
Should I hold or sell Palisade Bio Inc. stock in 2025Market Activity Summary & Entry Point Strategy Guides - newser.com
Palisade Bio Receives Canadian Patent for Composition of Product Candidate PALI-2108 - MarketScreener
Palisade Bio receives Canadian patent for inflammatory bowel drug - Investing.com
Palisade Bio Announces Grant of Patent for PALI-2108, a First-in-Class PDE4 Inhibitor for Fibrostenotic Crohn’s Disease and Ulcerative Colitis - Quiver Quantitative
PALI-2108 patent No. 3,174,137 protects drug through May 28, 2041 — Palisade Bio targets FSCD & UC - Stock Titan
Will Palisade Bio Inc. stock recover after recent dropJuly 2025 EndofMonth & Free Low Drawdown Momentum Trade Ideas - newser.com
What analysts say about Palisade Bio Inc stockResistance Breakout Alerts & Rapid Portfolio Strategies - earlytimes.in
Palisade Bio Inc. stock trend outlook and recovery pathWeekly Market Report & Weekly High Conviction Trade Ideas - newser.com
Palisade Bio, Inc. Cancels Special Meeting of Stockholders - TradingView
Palisade Bio Announces Cancellation of Special Meeting of Stockholders - GlobeNewswire
Special Meeting Cancelled: Palisade Bio Withdraws Proxy Proposals After Failing to Secure Quorum - Stock Titan
Cohen's Point72 Pours $14M in This Biotech Stock That… - inkl
Statistical indicators supporting Palisade Bio Inc.’s strengthMarket Trend Summary & Stepwise Swing Trade Plans - newser.com
How to forecast Palisade Bio Inc. trends using time seriesRate Cut & Reliable Intraday Trade Alerts - newser.com
Why Palisade Bio Inc. (7NS0) stock could outperform next yearJuly 2025 Reactions & Fast Exit/Entry Strategy Plans - newser.com
Ranking Palisade Bio Inc. among high performing stocks via toolsInsider Buying & Breakout Confirmation Trade Signals - newser.com
After-Hours Surge: Turn Therapeutics Rockets 134% Post-Close On Nasdaq Debut; Biotech Stocks Rally - RTTNews
Steven Cohen Doubles The S&P 500 — And His Next Bet's All Gut - Sahm
Biotech Stocks Surge After Hours: PCSA, PALI, And QTTB Lead On Volume And Speculation - Nasdaq
Is It Too Late to Buy Palisade Bio? - StocksToTrade
Palisade Bio Launches Phantom Unit Plan for Employees - MSN
Palisade Bio Stock Climbs To 9-Month High After $120M Stock Offering; Retail Sees More Gains Ahead - MSN
Palisade Bio Inc Azioni (PALI) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Palisade Bio Inc Azioni (PALI) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Wei Binxian | Director |
Nov 21 '24 |
Option Exercise |
0.00 |
388 |
0 |
855 |
2.96%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):